您好,欢迎登录Mr.confs会先生官方网站!

ICPP 2021: 15. International Conference on Pharmacoepidemiology and Pharmacovigilance

时间:2021-05-03 至 2021-05-04

ICPP 2021: 15. International Conference on Pharmacoepidemiology and Pharmacovigilance
收藏0
ICPP 2021: 15. International Conference on Pharmacoepidemiology and Pharmacovigilance
会议时间:2021-05-03 至 2021-05-04
会议地点: Rome, Italy,Rome,Italy 周边酒店预订

发票类型: 不支持开票
参会凭证:其它

门票信息
Participation Type Early Registration Fees Registration Fees
Non-Student Oral/Poster Presenter Registration € 450 € 500
Student Oral/Poster Presenter Registration € 350 € 400
Listener Registration € 250 € 300
Additional Paper Publication € 100
会议介绍

The International Research Conference Aims and Objectives

The International Research Conference is a federated organization dedicated to bringing together a significant number of diverse scholarly events for presentation within the conference program. Events will run over a span of time during the conference depending on the number and length of the presentations. With its high quality, it provides an exceptional value for students, academics and industry researchers.

ICPP 2021: 15. International Conference on Pharmacoepidemiology and Pharmacovigilance aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Pharmacoepidemiology and Pharmacovigilance. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Pharmacoepidemiology and Pharmacovigilance

Call for Contributions

Prospective authors are kindly encouraged to contribute to and help shape the conference through submissions of their research abstracts, papers and e-posters. Also, high quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or theoretical work in all areas of Pharmacoepidemiology and Pharmacovigilance are cordially invited for presentation at the conference. The conference solicits contributions of abstracts, papers and e-posters that address themes and topics of the conference, including figures, tables and references of novel research materials.

Guidelines for Authors

Please ensure your submission meets the conference's strict guidelines for accepting scholarly papers. Downloadable versions of the check list for Full-Text Papers and Abstract Papers.

Please refer to the Paper Submission Guideline, Abstract Submission Guideline and Author Information before submitting your paper.

Conference Proceedings

All submitted conference papers will be blind peer reviewed by three competent reviewers. The peer-reviewed conference proceedings are indexed in the Open Science Index, Google Scholar, Semantic Scholar, Zenedo, OpenAIRE, BASE, WorldCAT, Sherpa/RoMEO, and other index databases. Impact Factor Indicators.

Special Journal Issues

ICPP 2021 has teamed up with the Special Journal Issue on Pharmacoepidemiology and Pharmacovigilance. A number of selected high-impact full text papers will also be considered for the special journal issues. All submitted papers will have the opportunity to be considered for this Special Journal Issue. The paper selection will be carried out during the peer review process as well as at the conference presentation stage. Submitted papers must not be under consideration by any other journal or publication. The final decision for paper selection will be made based on peer review reports by the Guest Editors and the Editor-in-Chief jointly. Selected full-text papers will be published online free of charge.

Conference Sponsor and Exhibitor Opportunities

The Conference offers the opportunity to become a conference sponsor or exhibitor. To participate as a sponsor or exhibitor, please download and complete the Conference Sponsorship Request Form.

Selected Papers

  1. A Cross-Sectional Study on Board Certified Pharmacists in Arab Countries 2018 Update
    Mohamed Anwar Hammad, Khaled Mohamed Al Akhali, Yasmin Elsobky
  2. The Effect of Foreign Owned Firms and Licensed Manufacturing Agreements on Innovation: Case of Pharmaceutical Firms in Developing Countries
    Ilham Benali, Nasser Hajji, Nawfal Acha
  3. The Attitude of Second Year Pharmacy Students towards Lectures, Exams and E-Learning
    Ahmed T. Alahmar
  4. Comparison of the Use of Vaccines or Drugs against Parasitic Diseases
    H. Al-Khalaifa, A. Al-Nasser
  5. Assessment of Drug Delivery Systems from Molecular Dynamic Perspective
    M. Rahimnejad, B. Vahidi, B. Ebrahimi Hoseinzadeh, F. Yazdian, P. Motamed Fath, R. Jamjah
  6. Analysis of Pharmaceuticals in Influents of Municipal Wastewater Treatment Plants in Jordan
    O. A. Al-Mashaqbeh, A. M. Ghrair, D. Alsafadi, S. S. Dalahmeh, S. L. Bartelt-Hunt, D. D. Snow
  7. Silicon-To-Silicon Anodic Bonding via Intermediate Borosilicate Layer for Passive Flow Control Valves
    Luc Conti, Dimitry Dumont-Fillon, Harald van Lintel, Eric Chappel
  8. Patient Support Program in Pharmacovigilance: Foster Patient Confidence and Compliance
    Atul Khurana, Rajul Rastogi, Hans-Joachim Gamperl
  9. 21st Century Biotechnological Research and Development Advancements for Industrial Development in India
    Monisha Isaac
  10. Formulation of Extended-Release Gliclazide Tablet Using a Mathematical Model for Estimation of Hypromellose
    Farzad Khajavi, Farzaneh Jalilfar, Faranak Jafari, Leila Shokrani
  11. Honey Contamination in the Republic of Kazakhstan
    B. Sadepovich Maikanov, Z. Shabanbayevich Adilbekov, R. Husainovna Mustafina, L. Tyulegenovna Auteleyeva
  12. Intellectual Property Rights and Health Rights: A Feasible Reform Proposal to Facilitate Access to Drugs in Developing Countries
    M. G. Cattaneo
  13. Preparation of Polymer-Stabilized Magnetic Iron Oxide as Selective Drug Nanocarriers to Human Acute Myeloid Leukemia
    Kheireddine El-Boubbou
  14. Management Software for the Elaboration of an Electronic File in the Pharmaceutical Industry Following Mexican Regulations
    M. Peña Aguilar Juan, Ríos Hernández Ezequiel, R. Valencia Luis
  15. Risk of Occupational Exposure to Cytotoxic Drugs: The Role of Handling Procedures of Hospital Workers
    J. Silva, P. Arezes, R. Schierl, N. Costa
Faris Abachi University of Mosul, IQ
Luisetto Mauro IMA Academy, IT
Pankaj Thakur Italian Institute of Technology ([email protected]), Naples, IT
Gang Ren Lawrence Berkeley National Lab, US
Priyanka Sabharwal Health Partners Medical Group, US
Sivaramakrishna Yadavalli University of Houston, US
Shazia Bano Harvard Medical School, Massachusetts General Hospital , , US
Manju Bhaskar National Institutes of Health, US
Lei Mei Agilent Technologies, US
Chun Wu Mount Marty College, US
Ankit Gupta University of Chicago, US
Kal Ramnarayan Sapient Discovery, US
Xintong Wang Vanderbilt University, US
Gwo-Yu Chuang National Institutes of Health, US
Shashikant srivastava UT Southwestern Medical Center, US
Mohan Boggara Rensselaer Polytechnic Institute, US
Chandan Thomas Lake Erie college of Osteopathic Medicine School of Pharmacy, US
Subeena Sood Medstar Health Research Institute, US
Boojala Vijay B Reddy Queens College - City University of New York, US
Zhengwu Lu Abbott Laboratories, US
David Stiles Medtronic, US
Ching-An Peng Michigan Technological University, US
Bhupendra Prajapati Ganpat University,
Gihan Asaad National Research Centre, SA
Mai Abouhalawa National Research Center, Egypt, EG
Waleed Alhossan Prince Sultan Military Medical City, SA
Sulaiman C T Centre for Medicinal Plants Research, Arya Vaidya Sala, Kottakkal, IN
Saad Salman University of Peshawar , PK
Aisha Aziz Jinnah University For Women, PK
Berihan Abdelnor Minya University, EG
会议日程
Abstracts/Full-Text Paper Submission Deadline   January 06, 2020
Notification of Acceptance/Rejection   January 28, 2020
Final Paper (Camera Ready) Submission & Early Bird Registration Deadline   April 02, 2021
Conference Dates   May 03-04, 2021
参会指南
会议地点
×